Evidence map›Paper›PMID 39439493›Full record

ReviewExploration (Beijing, China)2024

Zhong Wang, Yongjie Zeng, Zubair Ahmed, Hui Qin, Ijaz Ahmad Bhatti, Huiliang Cao

Abstract readEnglish AbstractReview
In one paragraph

Review in Exploration (Beijing, China), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Exploration (Beijing, China) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhong WangInterfacial Electrochemistry and Biomaterials School of Materials Science and Engineering East China University of Science and Technology Shanghai China.
Yongjie ZengInterfacial Electrochemistry and Biomaterials School of Materials Science and Engineering East China University of Science and Technology Shanghai China.
Zubair AhmedInterfacial Electrochemistry and Biomaterials School of Materials Science and Engineering East China University of Science and Technology Shanghai China.
Hui QinDepartment of Orthopaedics Shanghai Jiaotong University Affiliated Sixth People's Hospital Shanghai China.
Ijaz Ahmad BhattiDepartment of Chemistry University of Agriculture Faisalabad Pakistan.
Huiliang CaoInterfacial Electrochemistry and Biomaterials School of Materials Science and Engineering East China University of Science and Technology Shanghai China.ORCID https://orcid.org/0000-0002-5209-4497

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial infection remains a major complication answering for the failures of various implantable medical devices. Tremendous extraordinary advances have been published in the design and synthesis of antimicrobial materials addressing this issue; however, the clinical translation has largely been blocked due to the challenge of balancing the efficacy and safety of these materials. Here, calcium's biochemical features, natural roles in pathogens and the immune systems, and advanced uses in infection medications are illuminated, showing calcium is a promising target for developing implantable devices with less infection tendency. The paper gives a historical overview of biomedical uses of calcium and summarizes calcium's merits in coordination, hydration, ionization, and stereochemistry for acting as a structural former or trigger in biological systems. It focuses on the involvement of calcium in pathogens' integrity, motility, and metabolism maintenance, outlining the potential antimicrobial targets for calcium. It addresses calcium's uses in the immune systems that the authors can learn from for antimicrobial synthesis. Additionally, the advances in calcium's uses in infection medications are highlighted to sketch the future directions for developing implantable antimicrobial materials. In conclusion, calcium is at the nexus of antimicrobial defense, and future works on taking advantage of calcium in antimicrobial developments are promising in clinical translation.

Identifiers

PMID39439493
PMCPMC11491315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.